Winston & Strawn

Site Search

Professionals (363)
Capabilities (78)
Experience (135)
Insights & News (2,135)
Other Results (83)

Professionals 363 results

Sandra Edwards

Partner

San Francisco

+1 415-591-1412

vCard

Partner

San Francisco

Christopher Essig

Partner

Chicago

+1 312-558-6229

vCard

Partner

Chicago

Terry Dee

Partner

Chicago

+1 312-558-8112

vCard

Partner

Chicago

View All Professionals

Capabilities 78 results

Practice Area

Product Liability & Mass Torts

Major multinational companies trust Winston to defend their products and reputations in high-profile, high-stakes product liability and mass tort claims. Our Product Liability & Mass Torts Practice is one of the industry’s most seasoned, with a deep bench of experienced lawyers and a unique combination of extensive trial experience and expansive technical knowledge....Read more

Practice Area

Derivatives & Structured Products

Winston represents swap dealers, major swap participants, financial intermediaries, hedge funds, national exchanges, and end-users in a broad array of derivative transactions ranging from highly structured transactions to more traditional trading or hedging transactions, and in regulatory and enforcement issues related to commodities and derivatives....Read more

Industry

Medical Devices

The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative healthcare landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Healthcare & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions....Read more

Experience 135 results

Experience

March 16, 2026

Winston advised La Phocéenne de Cosmétique in connection with the acquisition of Laboratoires de Biarritz.

Winston & Strawn LLP Paris advised La Phocéenne de Cosmétique in connection with the acquisition of Laboratoires de Biarritz....Read more

Experience

March 4, 2026

End of the Line: Winston Wins Unanimous Supreme Court Victory Against NJ Transit

In a unanimous decision authored by Justice Sotomayor, the U.S. Supreme Court held that NJ Transit is not an arm of the State of New Jersey and therefore is not entitled to sovereign immunity. The ruling means that plaintiffs injured by NJ Transit outside of New Jersey—such as in Pennsylvania and New York—may pursue claims in the courts of the states where their injuries occurred. The court adopted Winston’s position that state-created corporations that are formally liable for their own judgments are not arms of the state, reversing the Pennsylvania Supreme Court’s dismissal of Cedric Galette’s negligence suit while affirming the New York Court of Appeals’ decision allowing Jeffrey Colt’s case to proceed....Read more

Experience

March 3, 2026

Representing Farmer Bros in its Sale to Royal Cup

Winston & Strawn LLP is representing Farmer Bros. Co. (Nasdaq: FARM), a leading roaster, wholesaler and distributor of coffee, tea and allied products, in its sale to Royal Cup, Inc., a manufacturer and distributor of premium coffee and tea and portfolio company of Dallas-based private equity firm Braemont Capital, in an all-cash transaction. ...Read more

View All Experience

Insights & News 2,135 results

Recognitions

April 3, 2026

1 Min Read

John Drosick Named Among National LGBTQ+ Bar Association’s 2026 Best LGBTQ+ Lawyers Under 40

Winston & Strawn associate John Drosick has been recognized among the National LGBTQ+ Bar Association’s 2026 Best LGBTQ+ Lawyers Under 40. Each year, the National LGBTQ+ Bar recognizes LGBTQ+ legal professionals under the age of 40 who have distinguished themselves in their field and demonstrated a profound commitment to the LGBTQ+ equality....Read more

Product Liability & Mass Torts Digest

April 3, 2026

8 Min Read

A Recipe for Exclusion: Why the Baby Food MDL Experts Failed Under Daubert

In a high-stakes decision on expert exclusion authored late last month, the District Court for the Northern District of California granted defendants’ motion to exclude plaintiffs’ general causation expert witnesses in In re Baby Food Products Liability Litigation—a consolidated mass tort of over 100 pending cases regarding the alleged presence of toxic heavy metals in baby food.

Benefits Blast

April 2, 2026

5 Min Read

DOL Proposes Safe Harbor for Alternative Investments in 401(k) Plans

The U.S. Department of Labor (the DOL) has published its long-awaited proposed rule on selecting alternative investments in participant-directed 401(k) plans.

View All Insights & News

Other Results 83 results

Law Glossary

What Are Interchangeable Biological Products?

A biological product is interchangeable if it is biosimilar to the reference product and is expected to produce the same clinical result as the reference product in any given patient. A biosimilar product that is deemed to be interchangeable by the FDA means the biosimilar product can be substituted for the reference product by a pharmacist without consulting the prescriber. The specific requirements for substitution vary by state....Read more

Site Content

What Is General Causation?

In the product liability context, general causation is the legal and scientific determination of whether the product in question has the inherent capability to cause the alleged injury under certain circumstances. Establishment of general causation is a critical aspect of a plaintiff’s case, and typically requires scientific evidence, such as epidemiology or toxicology, and expert testimony to establish a causal connection between the product’s design, manufacturing, or warnings and the injury or injuries at issue. As contrasted to specific causation, the focus in a general causation inquiry is on whether the product or exposure, as a general matter, can cause the type of injury claimed by the plaintiff. A general causation inquiry does not assess any facts unique to a particular plaintiff....Read more

Site Content

What Is a Biosimilar?

A subset of biologics, a biosimilar is a biologic that is highly similar to an FDA-approved product, referred to as the reference product. Biosimilars have no clinically meaningful differences compared to a reference product in terms of safety, purity, and potency as demonstrated through human pharmacokinetic and pharmacodynamics studies. Because of their complexity, biosimilars are unlikely to be identical replicates of their comparable reference products....Read more